熱門資訊> 正文
Autonomix获得涵盖专有导管技术的专利
2024-04-16 21:47
- Autonomix Medical (NASDAQ:AMIX) on Tuesday announced that the U.S. patent office issued a patent entitled “Systems and Methods for Treating Cancer and/or Augmenting Organ Function.”
- The issued patent is directed to technology including, but not limited to, systems, methods, and devices for interventionally treating cancerous tumors and cancer-related pain, the company added.
- AMIX said it is initially advancing the development of its technology to address pancreatic cancer-related pain.
- Source: Press Release
More on Autonomix Medical, Inc.
- Spotlight On Nvidia, Walmart, Palo Alto Networks And CAGNY Conference
- Autonomix announces positive preclinical study for its catheter-based sensing technology
- Financial information for Autonomix Medical, Inc.
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
